International Journal of Radiation Oncology * Biology * Physics
Volume 61, Issue 1 , Pages 1-2 , January 2005

Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency-sparing radiotherapy?

  • Mack Roach III, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California San Francisco, UCSF/Mt. Zion NCI-Designated Comprehensive Cancer, San Francisco, CA
    • Department of Urology, University of California San Francisco, UCSF/Mt. Zion NCI-Designated Comprehensive Cancer, San Francisco, CA
    • Corresponding Author InformationReprint requests to: Mack Roach III, M.D., Department of Radiation Oncology, UCSF Comprehensive Cancer Center, 1600 Divisadero Street, Suite H-1031, San Francisco, CA 94143–1708. Tel: (415) 353-7175; Fax: (415) 353-9883

Received 12 May 2004 ,Accepted 18 May 2004.

References 

  1. McLaughlin PW, Narayana V, Meriowitz A, et al. Vessel sparing prostate radiotherapy: Dose limitation to critical erectile vascular structures (internal pudental artery and corpus cavernosum) defined by MRI. Int J Radiat Oncol Biol Phys 2005;61:20–31.
  2. Roach M , Faillace-Akazawa P , Malfatti C , et al.  Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy . Int J Radiat Oncol Biol Phys . 1996;35:1011–1018
  3. Kagawa K , Lee WR , Schultheiss TE , et al.  Clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy . Int J Radiat Oncol Biol Phys . 1996;36:246
  4. Roach M , Blasko JC Perez CA , et al.  Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria . Radiology . 2000;215:1441–1448
  5. Lee WR , Roach M , Michalski J , et al.  Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy . Int J Radiat Oncol Biol Phys . 2002;54:457–461
  6. Roach M , Pickett B , F-Akazawa P , et al.  Implementation of newer radiotherapeutic technology in the management of prostate cancer . In:  Mittal B , PurdyJ  editor. Advances in radiation therapy. Vol 1. 1st ed . Norwell, MA: Kluwer Academic Publishers; 1998;p. 247–268
  7. Fisch BM , Pickett B , Weinberg V , et al.  Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer . Urology . 2001;57:955–959
  8. Merrick GS , Wallner K , Butler WM , et al.  A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction . Int J Radiat Oncol Biol Phys . 2001;50:597–604
  9. Roach M, Winter K, Michalski JM, et al. Penile bulb dose and impotence following 3D conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective multi-institutional Phase I-II dose escalation study. Int J Radiat Oncol Biol Phys 2004;60:1351–1356.
  10. Millender LE, Aubin M , Pouliot J , Shinohara K , Roach M . Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer . Int J Radiat Oncol Biol Phys . 2004;59:6–10

PII: S0360-3016(04)00843-0

doi: 10.1016/j.ijrobp.2004.05.038

International Journal of Radiation Oncology * Biology * Physics
Volume 61, Issue 1 , Pages 1-2 , January 2005

Article Tools